CervoMed (CRVO) News Today $8.50 +0.79 (+10.25%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$8.64 +0.15 (+1.71%) As of 03/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period D. Boral Capital Reaffirms Buy Rating for CervoMed (NASDAQ:CRVO)March 28 at 2:53 AM | americanbankingnews.comChardan Capital Decreases Earnings Estimates for CervoMedMarch 28 at 2:04 AM | americanbankingnews.comCervoMed (CRVO) Projected to Post Quarterly Earnings on FridayCervoMed (NASDAQ:CRVO) will be releasing earnings before the market opens on Friday, April 4, Financial Modeling Prep reports.March 28 at 1:04 AM | marketbeat.comCervoMed (NASDAQ:CRVO) Given Buy Rating at D. Boral CapitalD. Boral Capital restated a "buy" rating and issued a $10.00 price target on shares of CervoMed in a report on Wednesday.March 27 at 8:26 AM | marketbeat.comCervoMed Announces Oral Presentation at 19th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurologic Disorders (AP/PD™)March 25 at 8:00 AM | globenewswire.comResearch Analysts Issue Forecasts for CervoMed Q1 EarningsMarch 22, 2025 | americanbankingnews.comCervoMed Inc trading resumesMarch 21, 2025 | markets.businessinsider.comCervoMed Inc trading halted, volatility trading pauseMarch 21, 2025 | markets.businessinsider.comCervoMed Q1 EPS Increased by Brookline Capital ManagementCervoMed Inc. (NASDAQ:CRVO - Free Report) - Stock analysts at Brookline Capital Management upped their Q1 2025 EPS estimates for CervoMed in a research report issued to clients and investors on Tuesday, March 18th. Brookline Capital Management analyst T. Bussian now anticipates that the company wMarch 21, 2025 | marketbeat.comRoth Capital Issues Negative Outlook for CervoMed EarningsCervoMed Inc. (NASDAQ:CRVO - Free Report) - Investment analysts at Roth Capital dropped their Q1 2025 earnings per share (EPS) estimates for shares of CervoMed in a report issued on Tuesday, March 18th. Roth Capital analyst B. Pachaiyappan now expects that the company will post earnings of ($0.80March 21, 2025 | marketbeat.comRoth Capital Forecasts CervoMed's Q1 Earnings (NASDAQ:CRVO)March 21, 2025 | americanbankingnews.comEquities Analysts Set Expectations for CervoMed Q1 EarningsCervoMed Inc. (NASDAQ:CRVO - Free Report) - Research analysts at Roth Capital issued their Q1 2026 earnings per share (EPS) estimates for CervoMed in a report issued on Tuesday, March 18th. Roth Capital analyst B. Pachaiyappan forecasts that the company will post earnings of ($0.52) per share forMarch 20, 2025 | marketbeat.comRoth Mkm Forecasts Strong Price Appreciation for CervoMed (NASDAQ:CRVO) StockMarch 20, 2025 | americanbankingnews.com3CRVO : Peering Into CervoMed's Recent Short InterestMarch 19, 2025 | benzinga.comIs CervoMed Inc. (CRVO) Among the Best Short Squeeze Stocks to Buy According to Analysts?March 19, 2025 | msn.comCervoMed (NASDAQ:CRVO) Price Target Raised to $20.00Roth Mkm lifted their price target on CervoMed from $15.00 to $20.00 and gave the stock a "buy" rating in a research note on Tuesday.March 19, 2025 | marketbeat.comCervoMed (NASDAQ:CRVO) Price Target Raised to $21.00 at Canaccord Genuity GroupCanaccord Genuity Group upped their price objective on shares of CervoMed from $12.00 to $21.00 and gave the company a "buy" rating in a report on Tuesday.March 19, 2025 | marketbeat.comCervoMed (NASDAQ:CRVO) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysMarch 19, 2025 | americanbankingnews.comCervoMed (NASDAQ:CRVO) Given "Buy" Rating at D. Boral CapitalMarch 19, 2025 | americanbankingnews.comChardan Capital upgrades CervoMed (CRVO) to a BuyMarch 18, 2025 | markets.businessinsider.comCervoMed price target raised to $20 from $15 at Roth MKMMarch 18, 2025 | markets.businessinsider.comCervoMed price target raised to $21 from $12 at CanaccordMarch 18, 2025 | markets.businessinsider.comCervoMed Inc. (CRVO): The Best Short-Term Stock to Buy Right NowMarch 18, 2025 | msn.comCervoMed (NASDAQ:CRVO) Receives "Buy" Rating from D. Boral CapitalD. Boral Capital reiterated a "buy" rating and issued a $10.00 price objective on shares of CervoMed in a research note on Monday.March 18, 2025 | marketbeat.comCervoMed (NASDAQ:CRVO) Issues Earnings ResultsCervoMed (NASDAQ:CRVO - Get Free Report) announced its earnings results on Monday. The company reported ($0.80) earnings per share for the quarter, missing analysts' consensus estimates of ($0.67) by ($0.13). CervoMed had a negative return on equity of 44.11% and a negative net margin of 118.68%.March 18, 2025 | marketbeat.comCervoMed reports FY24 EPS ($2.02), consensus ($1.85)March 17, 2025 | markets.businessinsider.comCervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdatesMarch 17, 2025 | markets.businessinsider.comCervoMed sees cash runway into mid-2026March 17, 2025 | markets.businessinsider.comWe Think CervoMed (NASDAQ:CRVO) Can Afford To Drive Business GrowthMarch 14, 2025 | uk.finance.yahoo.comJones Trading Upgrades CervoMed (CRVO)March 14, 2025 | msn.comCervoMed upgraded to Buy from Hold at JonesResearchMarch 13, 2025 | markets.businessinsider.comCervoMed upgraded to Buy at JonesResearch on more confidence in DLB programMarch 13, 2025 | markets.businessinsider.comChardan Capital Upgrades CervoMed (CRVO)March 13, 2025 | msn.comCervoMed upgraded to Buy from Neutral at ChardanMarch 13, 2025 | markets.businessinsider.comCervoMed price target raised to $15 from $7 at Roth MKMMarch 11, 2025 | markets.businessinsider.comJonesTrading Sticks to Its Hold Rating for CervoMed (CRVO)March 11, 2025 | markets.businessinsider.comCervoMed announces results from extension phase of RewinD-LB studyMarch 10, 2025 | markets.businessinsider.comCervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy BodiesMarch 10, 2025 | globenewswire.comCervoMed upgraded to Buy from Hold at D. Boral CapitalFebruary 20, 2025 | markets.businessinsider.comD. Boral Capital Upgrades CervoMed (CRVO)February 19, 2025 | msn.comCervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia ConferenceJanuary 31, 2025 | finance.yahoo.comCervoMed provides update on neflamapimod DLB programJanuary 31, 2025 | markets.businessinsider.comCervoMed to Present at the 8th International Lewy Body Dementia ConferenceJanuary 29, 2025 | globenewswire.comCervoMed downgraded to Neutral from Buy at H.C. WainwrightDecember 17, 2024 | markets.businessinsider.comHC Wainwright & Co. Downgrades CervoMed (CRVO)December 17, 2024 | msn.comCervoMed (CRVO) was downgraded to a Hold Rating at H.C. WainwrightDecember 17, 2024 | markets.businessinsider.comCervoMed announces inducement grants under Nasdaq lisitng ruleDecember 13, 2024 | markets.businessinsider.comCervoMed Inc.: CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 12, 2024 | finanznachrichten.deCervoMed price target lowered to $12 from $65 at CanaccordDecember 12, 2024 | markets.businessinsider.comCervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 12, 2024 | globenewswire.com Remove Ads Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address CRVO Media Mentions By Week CRVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRVO News Sentiment▼0.530.78▲Average Medical News Sentiment CRVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRVO Articles This Week▼182▲CRVO Articles Average Week Remove Ads Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITOS News CDTX News ACB News TSVT News CRDF News OLMA News DRUG News LFCR News ENGN News FHTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRVO) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CervoMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CervoMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRVO Stock Free CRVO Stock Alerts